Mandos Health Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

Mandos Health General Information

Description

Developer of a biopharmaceutical drug intended to help patients who are affected with Niemann-Pick Type C1 disease. The company specializes in developing the Adrabetadex drug while collaborating with various partners, clinics, and organizations that are developing drugs for NPC1 diseases, enabling patients to access diagnostic and treatment options for NPC1 disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2101 Corporate Center Drive
  • Suite 100
  • Thousand Oaks, CA 91320
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 2101 Corporate Center Drive
  • Suite 100
  • Thousand Oaks, CA 91320
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mandos Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-2025 Completed Generating Revenue
To view Mandos Health’s complete valuation and funding history, request access »

Mandos Health Patents

Mandos Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10258641-B2 Hydroxypropyl beta-cyclodextrin compositions and methods Active 10-Jun-2015
US-10300086-B2 Hydroxypropyl beta-cyclodextrin compositions and methods Active 10-Jun-2015
US-10709730-B2 Hydroxypropyl beta-cyclodextrin compositions and methods Active 10-Jun-2015
US-10933083-B2 Hydroxypropyl beta-cyclodextrin compositions and methods Active 10-Jun-2015
US-11406657-B2 Hydroxypropyl beta-cyclodextrin compositions and methods Active 10-Jun-2015 A61K31/724
To view Mandos Health’s complete patent history, request access »

Mandos Health Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Render Capital Venture Capital Minority
To view Mandos Health’s complete investors history, request access »

Mandos Health Investments (1)

Mandos Health’s most recent deal was a Corporate Asset Purchase with Mallinckrodt Pharmaceuticals (Adrabetadex). The deal was made on 01-Jul-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mallinckrodt Pharmaceuticals (Adrabetadex) 01-Jul-2021 Corporate Asset Purchase Buildings and Property
To view Mandos Health’s complete investments history, request access »

Mandos Health FAQs

  • When was Mandos Health founded?

    Mandos Health was founded in 2021.

  • Where is Mandos Health headquartered?

    Mandos Health is headquartered in Thousand Oaks, CA.

  • What industry is Mandos Health in?

    Mandos Health’s primary industry is Pharmaceuticals.

  • Is Mandos Health a private or public company?

    Mandos Health is a Private company.

  • What is Mandos Health’s current revenue?

    The current revenue for Mandos Health is .

  • Who are Mandos Health’s investors?

    Render Capital has invested in Mandos Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process